Treatment of Suicidal Ideation in the Emergency Department Using Nitrous Oxide
Launched by UNIVERSITY HOSPITAL, TOURS · May 23, 2024
Trial Information
Current as of March 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Active suicidal ideations
- • Beck Scale for Suicidal Ideation score greater than or equal to 8
- • French speaking
- • Patient admitted to psychiatric emergency department
- • Capable of wearing a facial mask
- • Having signed an informed consent
- • Affiliated with social security
- Exclusion Criteria:
- • Psychotic disorder, neurodegenerative disease, known substance use disorder (excluding caffeine or tobacco), substance intoxication, unstable somatic pathology
- • Pregnancy or breastfeeding
- • Contraindication to the use of nitrous oxide
- • Legal incapacity
- • Participation in another drug clinical trial
- • Patient subject to compulsory care measures
Trial Officials
ANAIS VANDEVELDE, MD, PHD
Principal Investigator
CHRU de Tours
About University Hospital, Tours
The University Hospital of Tours, a leading academic medical institution in France, is dedicated to advancing healthcare through innovative clinical research and patient-centered care. With a strong emphasis on collaboration between researchers, clinicians, and community partners, the hospital fosters a dynamic environment for conducting high-quality clinical trials across various medical disciplines. Its commitment to excellence in patient safety, ethical standards, and scientific integrity positions the University Hospital of Tours as a pivotal contributor to the development of new therapies and health solutions, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tours, , France
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
